JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

Kodu・Aktsiate loetelu・Stryker Corp

Stryker Corp

Suletud

SektorTervishoid

295.4 1.45

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

290.08

Max

297.15

Põhinäitajad
By Trading Economics
Sissetulek	-10M 849M
Müük	1.1B 7.2B
P/E Sektori keskmine	39.215 67.147
Aktsiakasum	4.47
Dividenditootlus	1.04
Kasumimarginaal	11.839
Töötajad	56,000
EBITDA	351M 1.7B

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+35.56% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	1.04% 2.36%
Järgmine tulemuste avaldamine	30. juuli 2026
Järgmine dividendimakse kuupäev	30. juuli 2026
Järgmine aktsia dividendi kuupäev (ex-date)	29. juuni 2026

Turustatistika
By TradingEconomics
Turukapital	-11B 126B
Eelmine avamishind	293.95
Eelmine sulgemishind	295.4

Uudiste sentiment

By Acuity

71%

29%

324 / 347 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

373.92 / 383.99 Toetus ja vastupanu

Stryker Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

30. apr 2026, 20:41 UTC

Tulu

Stryker 1Q Sales, Profit Rise as it Dealt with Cyberattack

12. märts 2026, 21:42 UTC

Uudisväärsed sündmused

Stryker Says Cyberattack Disruption Is Continuing

11. märts 2026, 19:18 UTC

Suurimad hinnamuutused turgudel

Stryker Shares Down After Cyberattack Tied to Iran-Linked Group

29. jaan 2026, 22:05 UTC

Tulu

Stryker Logs Higher 4Q Profit On Sales Gains

30. okt 2025, 20:36 UTC

Tulu

Stryker Lifts Fiscal Year Sales View After 3Q Revenue Rises

30. apr 2026, 20:06 UTC

Tulu

Stryker 1Q Organic Net Sales Up 2.4%

30. apr 2026, 20:06 UTC

Tulu

Stryker Backs FY26 Adj EPS $14.90-Adj EPS $15.10 >SYK

30. apr 2026, 20:05 UTC

Tulu

Stryker Still Sees FY26 Organic Sales Grwoth 8% to 9.5%

30. apr 2026, 20:05 UTC

Tulu

Stryker 1Q Adj EPS $2.60 >SYK

30. apr 2026, 20:05 UTC

Tulu

Stryker 1Q EPS $1.93 >SYK

30. apr 2026, 20:05 UTC

Tulu

Stryker 1Q Net $745M >SYK

30. apr 2026, 20:05 UTC

Tulu

Stryker 1Q Sales $6.02B >SYK

30. apr 2026, 20:05 UTC

Tulu

Stryker 1Q Net $745M >SYK

30. apr 2026, 20:05 UTC

Tulu

Stryker 1Q Adj EPS $2.60 >SYK

30. apr 2026, 20:05 UTC

Tulu

Stryker 1Q EPS $1.93 >SYK

30. apr 2026, 20:05 UTC

Tulu

Stryker 1Q Sales $6B >SYK

9. apr 2026, 20:55 UTC

Tulu

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

9. apr 2026, 20:55 UTC

Tulu

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

9. apr 2026, 20:55 UTC

Tulu

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

16. märts 2026, 00:00 UTC

Uudisväärsed sündmused

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

30. jaan 2026, 17:03 UTC

Market Talk

Stryker's 4Q Results Signal 2026 Growth -- Market Talk

29. jaan 2026, 21:07 UTC

Tulu

Stryker Sees 2026 Organic Net Sales Growth 8%-9.5%

29. jaan 2026, 21:05 UTC

Tulu

Stryker 4Q Adj EPS $4.47 >SYK

5. nov 2025, 19:38 UTC

Tulu

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5. nov 2025, 17:00 UTC

Tulu

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

30. okt 2025, 20:21 UTC

Tulu

Stryker Lifts FY Sales View After 3Q Revenue Rises

30. okt 2025, 20:05 UTC

Tulu

Stryker 3Q Adj EPS $3.19 >SYK

30. okt 2025, 20:05 UTC

Tulu

Stryker 3Q EPS $2.22 >SYK

30. okt 2025, 20:05 UTC

Tulu

Stryker 3Q Sales $6.1B >SYK

30. okt 2025, 20:05 UTC

Tulu

Stryker 3Q Net $859M >SYK

Võrdlus sarnastega

Hinnamuutus

Stryker Corp Prognoos

Hinnasiht

By TipRanks

35.56% tõus

12 kuu keskmine prognoos

Keskmine 394.32 USD 35.56%

Kõrge 465 USD

Madal 315 USD

Põhineb 23 Wall Streeti analüütiku instrumendi Stryker Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

23 ratings

Osta

Hoia

Müü

Põhineb 23 analüütiku instrumendi Stryker Corp aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

373.92 / 383.99Toetus ja vastupanu

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

324 / 347 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.